Newsbenzinga
Summit Therapeutics Withdraws Previously Announced Proposed $500M Underwritten Public Offering Of Shares Due To Market Conditions
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…